An important question regarding these cases is whether special properties of the cancer itself (e.g., specific POLE mutations, a particular genomic or epigenetic context) or patient-related attributes (e.g., host’s immune competence), are responsible for the unfavorable disease dissemination. The gene discussed is POLE; the disease is cancer.